Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
johnson & johnson
nonalcoholic steatohepatitis
abbvie
aducanumab
affordable care act
alzheimer's disease
bayer
biogen
biotech
cancer
cancer immunotherapy
What
bio
drug
news
4
×
roundup
nash
biogen’s
companies
fda
road
aducanumab
alzheimer’s
amyloid
angst
approval
approved
aren’t
bagged
billions
biogen
biopharmaceutical
brammer
convo
developers
digital
disease
drugs
earlier
effects
epidemic
failure
failures
fatty
felt
frenzied
gene
growing
help
imminent
known
led
Language
Current search:
news
×
" seattle blog main "
×
deals
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More